Brinzolamide
Glaucoma · Rx
RxGlaucomaGlaucoma Cai Orange cap
| Strength | 1% suspension |
|---|---|
| Typical quantity | 10-15 mL bottle (generic available) |
| Cash cost / month | Low · ~$0-20 |
| Drug class | Topical carbonic anhydrase inhibitor |
| Mechanism of action | Carbonic anhydrase II inhibition reducing aqueous production. Formulated near neutral pH, so it stings less than dorzolamide but blurs more. |
| Indication / reason for use | Open-angle glaucoma and ocular hypertension; adjunct. |
| Usual adult dosing | 1 drop three times daily (twice daily as adjunct). Shake well. |
| Preservative | BAK 0.01% |
| Contact lenses | Remove lenses; reinsert after 15 minutes. |
| Common / important adverse effects | Blurred vision on instillation (common), bitter taste, dry eye, blepharitis; endothelial caution as for dorzolamide. |
| Contraindications & cautions | Severe renal impairment; sulfonamide allergy (labelled); compromised corneal endothelium. |
| Pregnancy / lactation | Avoid where possible. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Azopt |
| Practice notes | Switch here from dorzolamide when stinging is the limiting factor; switch away when instillation blur is. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.